Hutch News
Results per Page:
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
ASCO 2022: Equity, innovation and in-person
Hutch cancer researchers, clinicians share findings on clinical trial eligibility, Medicaid expansion, wearables to track symptoms and more
Patient-reported outcomes predict risk of not taking breast cancer drugs
From the Unger and Ramsey Labs, Cancer Epidemiology, Prevention & Control Program, Cancer Consortium
Tip Sheet: New MacArthur ‘genius,’ returning to school during COVID-19 and the science of race and racism
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
Summaries of recent Fred Hutch research findings and other news
Cancer clinical trials exclude too many patients: That’s changing
Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials
Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations
Summaries of recent Fred Hutch research findings and other news
Black with cancer: ‘It shouldn’t be different’
Hutch/UW Consortium health equity team works to reduce cancer risk and racial bias, improve care for Black communities and patients
Cancer clinical trials: Creativity in the face of COVID-19
Faced with a global pandemic, scientists prioritize safety, patient benefit
Fred Hutch researchers present virtually at the 2020 American Society of Clinical Oncology meeting
The latest findings on bladder cancer, pediatric cancer, gender disparities and the financial toxicity of cancer
High impact of positive and negative clinical trial results
From the Unger Group, Division of Public Health Sciences
Fred Hutch at ASCO: HPV vaccine uptake in U.S., immunotherapy and sarcoma, financial toxicity of cancer, health care disparities and more
The American Society of Clinical Oncology will hold its annual meeting May 31-June 4 in Chicago
Research shows structural barriers are the biggest reason for low participation in clinical trials
Findings in Journal of the National Cancer Institute shows patients don’t have enough opportunities for participation
Structural and clinical barriers keep 3 of 4 cancer patients from participating in trials
‘Patients are willing to participate in trials if they’re offered one’
Comorbidities impede clinical trial participation
From the Unger Group, Public Health Sciences Division
US cancer death rate has declined for at least 25 years
Fred Hutch experts weigh in on milestone report from American Cancer Society
How to boost cancer clinical trial participation
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients
Closing the rural-urban cancer survival gap
‘Guideline care’ in clinical trials erased cancer death-rate disparities
Prostate cancer risk: Medicare claims are a powerful link
From the Unger Group, Public Health Sciences Division
Acupuncture can curb AI-induced joint pain in some breast cancer patients
Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug